SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Mixed oncology-trial results are driving attention: traders cite BioNTechs BNT113 setback and modest breast-cancer benefit, while bulls point to other promising pipeline readouts and upcoming updates. Debate also reflects concern over the leadership transition and the time needed to turn the pipeline into commercial products.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios quarterly results beat expectations and lifted its full-year outlook, but a softer next-quarter organic growth forecast signaled deceleration and drove a sharp selloff. Traders are debating whether slowing messaging growth and weaker customer expansion outweigh the strong results, while some see the pullback as a potential bounce opportunity.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as traders discuss a shift from volatile technology and growth stocks toward dividend-paying value and defensive holdings amid market uncertainty. Many point to its recent strength and keep accumulating, while others question its yield and warn that rising Treasury yields or a return to tech could weigh on the fund.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Traders are focused on whether Q3 results will show that oral Wegovy demand and international expansion can offset concerns about Eli Lillys competitive lead in GLP-1 drugs. The community is divided: some see the pill rollout and low valuation as recovery potential, while others remain cautious about Novos execution, management and pipeline; the Hengrui licensing deal also drew debate as a longer-term pipeline move.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a fresh 52-week high has put TGTX in focus, with traders pointing to BRIUMVIs commercial growth and anticipation of earnings and upcoming subcutaneous data. Buyout and short-squeeze theories are circulating, but remain speculation; others see the rally as momentum ahead of those catalysts.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record sales and revenue growth but an EPS miss and weaker margins, sparked a sharp rally and renewed short-squeeze speculation; traders are also citing the SECs decision to close its investigation without recommending enforcement. The move has drawn competing views, with bulls focused on growth and squeeze potential while bears question profitability, guidance and valuation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff and persistent volatility dominate discussion, with traders pointing to broader weakness in miners and uncertainty over Sangdongs production ramp and near-term cash flows. Some remain bullish on tungsten-market fundamentals and the mines first shipment, while others say the investor-day discussion offered little new detail and are concerned about execution.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, supported by growth in Dupixent and Eylea HD, sparked a sharp share-price surge and a new 52-week high. Traders are broadly bullish on the breakout, while debating whether the move can hold or will retrace.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access at least 80,000 U.S. cell sites, including Crown Castles towers, have focused attention on the prospect of a major new leasing customer. Traders see potential tower revenue upside, while skeptics note that no agreement is signed and question whether SpaceXs wireless plans will translate into meaningful demand.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A steep selloff in Aehr shares is driving discussion as traders debate whether broader AI and semiconductor weakness, valuation concerns and bearish options flow point to more downside or an oversold setup ahead of earnings. Bulls are watching guidance, backlog and potential AI test-system orders, while skeptics question execution and the companys ability to justify its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kimbell Royalty to Report Q3 Earnings: What's in the Cards?

KRP gears up for Q3 2026 earnings, with higher oil prices and strong revenue growth estimates in focus. 

Stay Ahead of Market Uncertainty With BP, XOM, COP and E

BP, ExxonMobil, ConocoPhillips & Eni emerge as low-beta stock picks amid market volatility, supported by oil prices, upstream growth prospects and investments.

Magnolia Oil & Gas to Post Q3 Earnings: What's in Store for the Stock?

MGY gears up for Q3 earnings as strong production and lower drilling costs face headwinds from weaker prices, rising expenses and dilution.

Seadrill to Report Q3 Earnings: What's in Store for the Stock?

SDRL's Q3 earnings are expected to benefit from rising offshore drilling activity and a strong backlog, but higher operating costs could pressure profits.

ConocoPhillips (COP) Earnings Expected to Grow: Should You Buy?

ConocoPhillips (COP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ConocoPhillips to Report Q3 Earnings: What's in the Cards?

COP gears up for Q3 earnings with higher oil prices, strong profit and revenue growth estimates, and positive indicators pointing to a potential beat.

Here's Why ConocoPhillips (COP) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

ConocoPhillips (COP) Just Reclaimed the 50-Day Moving Average

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

ConocoPhillips (COP) Stock Declines While Market Improves: Some Information for Investors

The latest trading day saw ConocoPhillips (COP) settling at $147.96, representing a -2.25% change from its previous close.

ConocoPhillips (COP) Is Up 2.93% in One Week: What You Should Know 

Does ConocoPhillips (COP) have what it takes to be a top stock pick for momentum investors? Let's find out.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

Why Did XOM, COP, CVX Jump To 52-Week Highs Last Week?

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>U.S. West Texas Intermediate crude futures for December rose to $102.40 per barrel.</li><li>Last week, Houthi attacks on Saudi Arabia intensified, stoking fears about energy security and infrastructure and shipments across the Middle East.&nbsp;</li><li>Although oil shipments through the Strait of Hormuz have recovered toward pre-war levels in recent weeks, Citigroup analysts warn that the improvement may not reflect a sustained recovery.</li></ul>Shares of energy companies Exxon Mobil Corp. (XOM), ConocoPhillips (COP) and Chevron Corp. (CVX) surged to annual highs on Friday as oil prices rallied to a six-month high amid growing geopolitical tensions.&nbsp;Brent crude futures maturing in December&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uso-jumps-to-over-11-year-high-as-brent-tops-116-wti-crosses-100-amid-escalating-middle-east-tensions/cZxylsKRBxt">climbed</a> over $116 per barrel on Friday, while U.S. West Texas Intermediate (WTI) crude futures for December rose to $102.40 per barrel.<h2 class="st-heading-2">Why Are Fuel Prices Surging?</h2>Last week, Houthi attacks on Saudi Arabia intensified, stoking fears about energy security and infrastructure and shipments across the Middle East. Saudi Aramco evacuated its Dhahran headquarters after attacks in the country's eastern oil-producing region.While U.S. President Donald Trump said last week that Washington would not be negotiating with Tehran and suggested further developments could follow soon, on Sunday, he ruled out an attack on Iran this week.&nbsp;Meanwhile, though oil shipments through the Strait of Hormuz have recovered toward pre-war levels in recent weeks, with the U.S. Central Command aiding passage through the critical waterways, Citigroup analysts have warned that the recent improvement in shipments may not represent a sustained recovery. UBS analyst Giovanni Staunovo also reportedly told Reuters that any further escalation could trigger renewed supply disruptions.&nbsp;Brett Erickson, Managing Principal at Obsidian Risk Advisors, said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/BrettErickson28/status/2114339497307746459">post</a> on X over the weekend, “Iran is currently launching missiles and drones at vessels attempting to transit the Strait of Hormuz. Despite the preparations from all sides to ready for a full-scale resumption of the war, Iran does not intend to allow the U.S. to use this window to flow out excessive amount of oil and refined products in the meantime.”<h2 class="st-heading-2">XOM, COP, CVX Stocks: 52-Week Highs</h2>Exxon Mobil, ConocoPhillips and Chevron surged to 52-week highs on Friday amid the steep climb in oil prices.&nbsp;<a href="https://stocktwits.com/symbol/XOM">XOM stock</a> hit a 52-week high of $183.75 during trading hours on Friday, closing nearly 3% higher.&nbsp;<a href="https://stocktwits.com/symbol/COP">COP stock</a> rallied to a 52-week high of $152.77 during regular trading, and ended 3.5% higher at close.&nbsp;<a href="https://stocktwits.com/symbol/CVX">CVX stock</a> surged to a 52-week high of $ 233.74, closing up nearly 3%.&nbsp;On Stocktwits, retail sentiment around XOM and CVX stocks was ‘bullish’ at the time of writing, while it was ‘bearish’ for COP.&nbsp;XOM stock has gained more than 49% year-to-date, while COP and CVX stocks have surged nearly 56% and 50%, respectively.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Over the past year, BATL surged 253%, EONR climbed 111%, and USO advanced 105%. (Photo credit: Getty Images)

Exxon Mobil, ConocoPhillips and Chevron stocks surged to annual highs after Brent crude futures maturing in December climbed over $116 per barrel on Friday, hitting a six-month high.

Chevron Corp.

Exxon Mobil Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$154.03
Prev Close	$150.03
Open	$152.48
Dividend Yield	3.40%
50-Day Moving Average	$136.13
Beta	0.43
Avg. Volume	6.85M
PE Ratio	20.41

52-Week High	$154.28
52-Week Low	$85.57
Market Capitalization	$185.04B
EPS (Annual)	$6.35
Price to Book	2.83
Revenue Per Employee	$5.93M

Feed

News

Sentiment

Earnings

Futures

Fundamentals

Info

COP Fundamentals